Thrombogenicity associated with factor IX complex concentrates
Lusher, J.M.
Seminars in Hematology 28(3 Suppl 6: 3-5
1991
ISSN/ISBN: 0037-1963 PMID: 1780767 Document Number: 378758
Document emailed within 1 workday
Related Documents
Prowse, C.V.; Chirnside, A.; Elton, R.A. 1980: In vitro thrombogenicity tests of factor IX concentrates. I. A survey of available assays Thrombosis and Haemostasis 42(5): 1355-1367Aronson, D.L.; Menache, D. 1987: Thrombogenicity of factor IX complex: in vivo investigation Developments in Biological Standardization 67: 149-155
Lusher, J.M. 1993: Prediction and management of adverse events associated with the use of factor IX complex concentrates Seminars in Hematology 30(2 Suppl. 1): 36-40
Rosén, S. 2001: A rebuttal: Issues with the assay of factor VIII activity in plasma and factor VII concentrates Thrombosis and Haemostasis 86(4): 1132-1133
Allain, J.P. 1972: Study of the "in vivo" activity of factor VIIi or factor IX after injection of several concentrates: practical applications Nouvelle Revue Francaise d'Hematologie 12(2): 241-249
Hofmann, V.; Ermanni, M.; Straub, P.W. 1978: Thrombin formation in factor IX concentrates and FEIBA (factor eight inhibitor bypassing activity) (proceedings) Schweizerische Medizinische Wochenschrift 108(41): 1600
MacGregor, I.; Drummond, O.; Prowse, C. 1997: In vivo modelling of coagulation factor concentrate thrombogenicity Thrombosis and Haemostasis 77(2): 405-406
Escolar, G.; Carretero, M.; Magallón, M.; Quintana, M.; Arnau, C.; Castillo, R.; Aznar-Salatti, J. 1998: von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease Haematologica 83(11): 1009-1014
Nyman, D. 1975: Clinical use of factor IX concentrates Schweizerische Medizinische Wochenschrift 105(37): 1188-1190
Blatt, P.M.; Pearsall, A.H.; Givhan, E.G.; Hallum, C.E.; Roberts, H.R.; Webster, W.P. 1980: Haemostatic failure of prothrombin complex concentrates during elective dental procedure Thrombosis and Haemostasis 42(5): 1604-1606
Magner, A.; Aronson, D. 1979: Toxicity of factor IX concentrates in mice Developments in Biological Standardization 44: 185-188
Mariani, G.; Di Nucci, G.D.; Arcieri, P. 1994: Immunopurified clotting factor concentrates Nouvelle Revue Francaise d'Hematologie 36(Suppl 1): S61-S65
Vicente, V. 1989: Plasma concentrates of factor VIII. Where are we? Sangre 34(1): 1-3
Klarmann, D.; Kreuz, W.; Auerswald, G.; Auberger, K.; Rabenau, H.; Gürtler, L.; Roggendorf, M. 1995: Hepatitis C and pasteurised factor VIIi and IX concentrates Thrombosis and Haemostasis 73(4): 736-737
Rubinstein, D.B. 1995: Virus infection and clotting factor concentrates Lancet 345(8959): 1248
Yoshioka, A.; Shima, M.; Nishino, M.; Yoshikawa, N.; Fukui, H. 1987: In vitro characterization of various factor VIII concentrates Arzneimittel-Forschung 37(7): 753-756
Kröniger, A.; Kumpe, A.; Wormsbächer, W.; Herchenhahn, B. 1982: Factor VIIi concentrates. Problems and protein chemistry characterization Die Medizinische Welt 33(28): 1027-1033
Fricke, W.A.; Lamb, M.A.; Rastogi, S.C. 1993: Standards for assay of von Willebrand factor concentrates: a collaborative study Thrombosis and Haemostasis 70(2): 351-356
Okamoto, K.; Tamura, T.; Yamaguchi, K. 2011: Clinical trials of anticoagulants and anticoagulant factor concentrates for the management of DIC in Japan Rinsho Byori. Japanese Journal of Clinical Pathology Suppl 147: 95-103
Laurian, Y.; Dussaix, E.; Parquet, A.; Chalvon-Demersay, A.; d'Oiron, R.; Tchernia, G. 1994: Transmission of human parvovirus B19 by plasma derived factor VIIi concentrates Nouvelle Revue Francaise d'Hematologie 36(6): 449-453